FTC Supports NAD, But Does Not Mirror The CBBB Division’s Transparency
This article was originally published in The Tan Sheet
Executive SummaryThe federal and private entities monitoring dietary supplement health claims are not created equal, says attorney Anthony L. Young
You may also be interested in...
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.